Open-Label Single-Sequence Crossover Study Evaluating Pharmacokinetics, Efficacy, and Safety of Once-Daily Dosing of Nitisinone in Patients with Hereditary Tyrosinemia Type 1.

Guffon, Nathalie; Bröijersén, Anders; Palmgren, Ingrid; Rudebeck, Mattias; Olsson, Birgitta

Guffon, Nathalie; Bröijersén, Anders; Palmgren, Ingrid; Rudebeck, Mattias; Olsson, Birgitta.

Afiliação

Guffon N; Centre de Référence des Maladies Héréditaires du Métabolisme, Hôpital Femme Mère Enfant, 59 Boulevard Pinel, 69677, Bron, France.
Bröijersén A; Swedish Orphan Biovitrum (Sobi), 112 76, Stockholm, Sweden. anders.broijersen@sobi.com.
Palmgren I; Swedish Orphan Biovitrum (Sobi), 112 76, Stockholm, Sweden.
Rudebeck M; Swedish Orphan Biovitrum (Sobi), 112 76, Stockholm, Sweden.
Olsson B; Swedish Orphan Biovitrum (Sobi), 112 76, Stockholm, Sweden.

JIMD Rep ; 38: 81-88, 2018.

Article em En | MEDLINE | ID: mdl-28643275

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google